Decompressive craniectomy for intracerebral hemorrhage.

Area of Science:

• Neurosurgery
• Neurology
• Experimental Medicine

Background:

• Intracerebral hemorrhage (ICH) has poor outcomes, with high mortality and disability.
• Current treatments for ICH show limited benefit.
• Decompressive craniectomy is effective for ischemic stroke with swelling.

Purpose of the Study:

• To investigate the efficacy of decompressive craniectomy in improving outcomes after experimental intracerebral hemorrhage.
• To test the hypothesis that craniectomy can mitigate the adverse effects of hematoma and edema in ICH.

Main Methods:

• An experimental model of intracerebral hemorrhage was induced in rats via autologous blood injection into the basal ganglia.
• Animals underwent decompressive craniectomy at 1, 6, or 24 hours post-ICH, or received no craniectomy.
• Neurological, behavioral, and apoptosis assessments were performed.

Main Results:

• All decompressive craniectomy groups exhibited significantly lower mortality rates compared to the no-craniectomy group (P < 0.01).
• Neurological and behavioral outcomes were substantially improved in craniectomy groups (P < 0.001).
• A trend towards increased apoptosis was observed in the non-treated ICH group.

Conclusions:

• Decompressive craniectomy performed up to 24 hours after experimental ICH significantly improved survival and functional outcomes.
• Earlier intervention with decompressive craniectomy yielded greater benefits.
• This study supports the potential of decompressive craniectomy as a therapeutic option for ICH.